• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Synchrony Financial filed SEC Form 8-K: Other Events

    3/6/25 5:05:52 PM ET
    $SYF
    Finance: Consumer Services
    Finance
    Get the next $SYF alert in real time by email
    8-K
    false 0001601712 0001601712 2025-03-06 2025-03-06 0001601712 us-gaap:CommonStockMember 2025-03-06 2025-03-06 0001601712 us-gaap:SeriesAPreferredStockMember 2025-03-06 2025-03-06 0001601712 us-gaap:SeriesBPreferredStockMember 2025-03-06 2025-03-06

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): March 6, 2025

     

     

    SYNCHRONY FINANCIAL

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-36560   51-0483352

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    777 Long Ridge Road

    Stamford, Connecticut

      06902
    (Address of principal executive offices)   (Zip Code)

    (203) 585-2400

    (Registrant’s telephone number, including area code)

    N/A

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities Registered Pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common stock, par value $0.001 per share   SYF   New York Stock Exchange
    Depositary Shares Each Representing a 1/40th Interest in a Share of 5.625% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A   SYFPrA   New York Stock Exchange
    Depositary Shares Each Representing a 1/40th Interest in a Share of 8.250% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B   SYFPrB   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 8.01.

    Other Events

    On March 3, 2025, Synchrony Financial (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the several underwriters listed on Schedule I to the Underwriting Agreement (collectively, the “Underwriters”), to issue and sell $800,000,000 aggregate principal amount of 5.450% Fixed-to-Floating Rate Senior Notes due 2031 (the “Notes”) in a public offering pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-266264) (the “Registration Statement”) and a related prospectus, including the related prospectus supplement, filed with the Securities and Exchange Commission.

    The Notes will be governed by an Indenture, dated as of August 11, 2014 (the “Base Indenture”), between the Company and The Bank of New York Mellon, as trustee (the “Trustee”), as supplemented to March 6, 2025 and as further supplemented by a Thirteenth Supplemental Indenture, dated as of March 6, 2025 (the “Thirteenth Supplemental Indenture”), between the Company and the Trustee (as so supplemented, the “Indenture”).

    The foregoing summary of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the text of the Underwriting Agreement, which is filed as Exhibit 1.1 hereto and incorporated by reference into this Item 8.01 and into the Registration Statement. The foregoing summary of the Indenture does not purport to be complete and is qualified in its entirety by reference to the Thirteenth Supplemental Indenture filed as Exhibit 4.1 hereto, and the form of the Notes, which is included in Exhibit 4.1 hereto, each of which is incorporated by reference into this Item 8.01 and into the Registration Statement, the Twelfth Supplemental Indenture, which was filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on August 2, 2024, and the Base Indenture, which was filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on August 13, 2014.

    A copy of the opinion of Sidley Austin LLP, relating to the validity of the Notes, is incorporated by reference into the Registration Statement and is filed as Exhibit 5.1 hereto.

     

    Item 9.01.

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Number    Description

     1.1

       Underwriting Agreement, dated March 3, 2025, among Synchrony Financial and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the several underwriters listed on Schedule I thereto.

     4.1

       Thirteenth Supplemental Indenture, dated as of March 6, 2025, between Synchrony Financial and The Bank of New York Mellon, as Trustee.

     4.2

       Form of 5.450% Fixed-to-Floating Rate Senior Notes due 2031 (included in Exhibit 4.1 hereto).

     5.1

       Opinion of Sidley Austin LLP.

    23.1

       Consent of Sidley Austin LLP (included in Exhibit 5.1 hereto).

    104

       The cover page from this Current Report on Form 8-K, formatted in Inline XBRL


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        SYNCHRONY FINANCIAL
    Date: March 6, 2025     By:  

    /s/ Jonathan S. Mothner

        Name:   Jonathan S. Mothner
        Title:   Executive Vice President, Chief Risk and Legal Officer
    Get the next $SYF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SYF

    DatePrice TargetRatingAnalyst
    4/7/2025$44.00Overweight → Equal-Weight
    Morgan Stanley
    1/28/2025$70.00Buy → Neutral
    Compass Point
    1/6/2025$59.00 → $79.00Equal Weight → Overweight
    Barclays
    12/19/2024$40.00 → $82.00Underweight → Overweight
    Morgan Stanley
    12/9/2024$59.00 → $72.00Neutral → Overweight
    Analyst
    12/3/2024$60.00 → $85.00Equal Weight → Overweight
    Wells Fargo
    9/16/2024Buy → Neutral
    BTIG Research
    8/9/2024$54.00Neutral → Buy
    BofA Securities
    More analyst ratings